1. Berndl G. Rosenberg J. Liepold B.et al. (2011).Solid pharmaceutical dosage form. US Patent 8 025 899.
2. Blackshields C. McHugh C. Leonard T.et al. (2012).Impact of film properties and drug physicochemical properties on diffusion through a poly(viny alcohol) film for the development of Gires™.http://www.google.com/#pq=merrion+pharmaceuticals+ireland&hl=en&cp=29&gs_id=3d&xhr=t&q=merrion+pharmaceuticals+Gires&pf=p&sclient=psy‐ab&source=hp&pbx=1&oq=merrion+pharmaceuticals+Gires&aq=f&aqi=&aql=&gs_sm=&gs_upl=&bav=on.2 or.r_gc.r_pw. cf.osb&fp=f2900e4a30b61916&biw=1218&bih=561(accessed February 2012).
3. Buxton I.R. Currie R. Dela‐Cruz M.A.et al. (2009).Sustained release formulations comprising lamotrigine. EP 1 524 981 B1.
4. Cima M.J. Haggerty J.S. Sachs E.M. andWilliams P.A.(1993).Three‐dimensional printing techniques. US Patent 5 204 055.
5. Drugs and the Pharmaceutical Sciences;Coughlan D.C.,2008